Celldex Therapeutics | CLDX - Gross Profit On Sales

Stock Price
34.08
Daily Change
0.75 2.24%
Monthly
12.87%
Yearly
91.43%
Q2 Forecast
31.36

Celldex Therapeutics reported $121K in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Agenus USD 34.2M 4.61M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Celldex Therapeutics USD 121K 609K Dec/2025
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Roche Holding CHF 22.09B 10.04B Dec/2025